Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
BTMD biote Corp
- Stocks
- Healthcare
- NASDAQ: BTMD
Price (delayed)
$3.99
Market cap
$201.95M
P/E Ratio
5.7
Dividend/share
N/A
EPS
$0.7
Enterprise value
$269.63M
Highlights
The P/E is 81% less than the last 4 quarters average of 29.5
biote's gross profit has increased by 9% YoY and by 2.1% QoQ
The equity has plunged by 154% YoY but it has grown by 15% from the previous quarter
biote's quick ratio has plunged by 72% YoY but it has increased by 12% from the previous quarter
Key stats
What are the main financial stats of BTMD
Market
Valuations
Earnings
Shares outstanding
50.61M
Market cap
$201.95M
Enterprise value
$269.63M
Price to earnings (P/E)
5.7
Price to book (P/B)
N/A
Price to sales (P/S)
0.63
EV/EBIT
7.85
EV/EBITDA
6.93
EV/Sales
1.35
Revenue
$199.38M
Gross profit
$142.01M
Operating income
$30.87M
Net income
$21.8M
EBIT
$34.34M
EBITDA
$38.89M
Free cash flow
$36.59M
Per share
Balance sheet
Liquidity
EPS
$0.7
EPS diluted
$0.62
Free cash flow per share
$1.16
Book value per share
-$1.64
Revenue per share
$6.33
TBVPS
$3.45
Total assets
$123.38M
Total liabilities
$208.21M
Debt
$109.38M
Equity
-$89.98M
Working capital
$20.21M
Debt to equity
-1.22
Current ratio
1.42
Quick ratio
1.02
Net debt/EBITDA
1.74
Margins
Efficiency
Dividend
EBITDA margin
19.5%
Gross margin
71.2%
Net margin
10.9%
Operating margin
15.5%
Return on assets
19.8%
Return on equity
N/A
Return on invested capital
27.3%
Return on capital employed
45.8%
Return on sales
17.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BTMD stock price
How has the biote stock price performed over time
Intraday
1.53%
1 week
-0.75%
1 month
-2.68%
1 year
-39.08%
YTD
-35.44%
QTD
19.82%
Financial performance
How have biote's revenue and profit performed over time
Revenue
$199.38M
Gross profit
$142.01M
Operating income
$30.87M
Net income
$21.8M
Gross margin
71.2%
Net margin
10.9%
biote's gross profit has increased by 9% YoY and by 2.1% QoQ
The company's operating margin fell by 7% YoY and by 3.1% QoQ
BTMD's revenue is up by 6% year-on-year
biote's gross margin has increased by 2.7% YoY
Price vs fundamentals
How does BTMD's price correlate with its fundamentals
Growth
What is biote's growth rate over time
Valuation
What is biote stock price valuation
P/E
5.7
P/B
N/A
P/S
0.63
EV/EBIT
7.85
EV/EBITDA
6.93
EV/Sales
1.35
The P/E is 81% less than the last 4 quarters average of 29.5
The equity has plunged by 154% YoY but it has grown by 15% from the previous quarter
The stock's price to sales (P/S) is 37% less than its last 4 quarters average of 1.0
BTMD's revenue is up by 6% year-on-year
Efficiency
How efficient is biote business performance
BTMD's ROIC has soared by 160% year-on-year and by 139% since the previous quarter
The ROS has soared by 123% from the previous quarter and by 91% YoY
Dividends
What is BTMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BTMD.
Financial health
How did biote financials performed over time
biote's total assets is 41% lower than its total liabilities
biote's quick ratio has plunged by 72% YoY but it has increased by 12% from the previous quarter
The current ratio has shrunk by 70% YoY but it rose by 8% QoQ
The equity has plunged by 154% YoY but it has grown by 15% from the previous quarter
BTMD's debt to equity has surged by 62% year-on-year but it is down by 16% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.